Amundi Stoxx Europe 600 UCITS ETF (EPA: MEUD)
France
· Delayed Price · Currency is EUR 244.21
-0.04 (-0.02%)
Aug 30, 2024, 5:35 PM CET
17.39% (1Y)
| Assets | 8.34B |
| Expense Ratio | 0.07% |
| PE Ratio | 14.53 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +17.53% |
| Volume | 1,968 |
| Open | 242.65 |
| Previous Close | 244.25 |
| Day's Range | 242.65 - 245.10 |
| 52-Week Low | 222.81 |
| 52-Week High | 245.10 |
| Beta | 1.02 |
| Holdings | 601 |
| Inception Date | Apr 3, 2013 |
About MEUD
Amundi Stoxx Europe 600 UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management SAS. The fund invests in public equity markets of Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the Stoxx Europe 600 Net Return EUR Index, by investing in the stocks of companies as per their weightings in the index. Amundi Stoxx Europe 600 UCITS ETF was formed on August 2, 2010 and is domiciled in Luxembourg.
Asset Class Equity
Category Total Market
Stock Exchange Euronext Paris
Ticker Symbol MEUD
Provider Lyxor
Index Tracked STOXX Europe 600
Performance
MEUD had a total return of 17.53% in the past year. Since the fund's inception, the average annual return has been 8.14%, including dividends.
Top 10 Holdings
21.47% of assets| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/S | NOVO.B | 3.53% |
| ASML Holding N.V. | ASML | 2.91% |
| Nestle SA | NESN.SW | 2.30% |
| AstraZeneca PLC | AZN | 2.21% |
| Novartis AG Registered Shares | NOVN.SW | 2.00% |
| Roche Holding AG | ROG.SW | 1.92% |
| Shell plc | SHEL | 1.87% |
| SAP SE | SAP | 1.82% |
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | MC | 1.55% |
| TotalEnergies SE | TTE | 1.35% |